论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Comella K, Bell W
Received 24 May 2017
Accepted for publication 13 July 2017
Published 16 August 2017 Volume 2017:10 Pages 295—299
DOI https://doi.org/10.2147/IMCRJ.S142514
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Colin Mak
Peer reviewer comments 2
Editor who approved publication: Dr Ronald Prineas
Background: Stromal vascular fraction (SVF) is a mixture of cells which can be
isolated from a mini-lipoaspirate of fat tissue. Platelet-rich plasma (PRP) is
a mixture of growth factors and other nutrients which can be obtained from
peripheral blood. Adipose-derived stem/stromal cells (ADSCs) can be isolated
from fat tissue and expanded in culture. The SVF includes a variety of
different cells such as ADSCs, pericytes, endothelial/progenitor cells, and a
mix of different growth factors. The adipocytes (fat cells) can be removed via
centrifugation. Here, we describe the rationale and, to our knowledge, the
first clinical implementation of SVF and PRP followed by repeat dosing of
culture-expanded ADSCs into a patient with severe xerostomia postirradiation.
Methods: Approximately 120 mLs of adipose tissue was
removed via mini-lipoaspirate procedure under local anesthetic. The SVF was
prepared from half of the fat and resuspended in PRP. The mixture was delivered
via ultrasound directly into the submandibular and parotid glands on both the
right and left sides. The remaining 60 mLs of fat was processed to
culture-expand ADSCs. The patient received seven follow-up injections of the
ADSCs plus PRP at 5, 8, 16, 18, 23, 28, and 31 months postliposuction. The
subject was monitored over a period of 31 months for safety (adverse events),
glandular size via ultrasound and saliva production.
Results: Throughout the 31-month monitoring period, no safety
events such as infection or severe adverse events were reported. The patient
demonstrated an increase in gland size as measured by ultrasound which
corresponded to increased saliva production.
Conclusion: Overall, the patient reported improved quality of life
and willingness to continue treatments. The strong safety profile and
preliminary efficacy results warrant larger studies to determine if this is a
feasible treatment plan for patients postradiation.
Keywords: adipose tissue,
ADSCs, cell therapy, MSCs, PRP, stem cells, SVF, xerostomia
摘要视频链接:Intraglandular implantation
of SVF and ADSCs plus PRP